Skip to main content
SpringerLink
Log in

Adverse drug reactions with medicines of unknown identity

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Caillet C, et al. Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People's Democratic Republic. Drug Safety : 20 May 2017. Available from: URL: http://doi.org/10.1007/s40264-017-0544-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adverse drug reactions with medicines of unknown identity. Reactions Weekly 1654, 10 (2017). https://doi.org/10.1007/s40278-017-30743-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-30743-7

Search

Navigation